INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 78 filers reported holding INTELLIA THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 1.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $210,000 | +72.1% | 10,000 | 0.0% | 0.11% | +35.4% |
Q1 2020 | $122,000 | -17.0% | 10,000 | 0.0% | 0.08% | +8.2% |
Q4 2019 | $147,000 | +9.7% | 10,000 | 0.0% | 0.07% | 0.0% |
Q3 2019 | $134,000 | -18.3% | 10,000 | 0.0% | 0.07% | -19.8% |
Q2 2019 | $164,000 | -4.1% | 10,000 | 0.0% | 0.09% | -9.0% |
Q1 2019 | $171,000 | +25.7% | 10,000 | 0.0% | 0.10% | +12.4% |
Q4 2018 | $136,000 | -52.4% | 10,000 | 0.0% | 0.09% | -42.9% |
Q3 2018 | $286,000 | -41.0% | 10,000 | -50.0% | 0.16% | +13.9% |
Q2 2018 | $485,000 | +129.9% | 20,000 | +100.0% | 0.14% | +14.2% |
Q1 2018 | $211,000 | -45.1% | 10,000 | -50.0% | 0.12% | +14.3% |
Q4 2017 | $384,000 | -5.9% | 20,000 | 0.0% | 0.10% | -12.5% |
Q3 2017 | $408,000 | +155.0% | 20,000 | +100.0% | 0.12% | +25.0% |
Q2 2017 | $160,000 | +13.5% | 10,000 | 0.0% | 0.10% | +10.3% |
Q1 2017 | $141,000 | – | 10,000 | – | 0.09% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Darwin Global Management, Ltd. | 752,024 | $100,884,000 | 18.57% |
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 420,859 | $56,458,000 | 4.40% |
Discovery Value Fund | 922,411 | $123,741,000 | 3.63% |
MPM BioImpact LLC | 162,620 | $21,815,000 | 3.38% |
Ally Bridge Group (NY) LLC | 65,000 | $8,720,000 | 2.56% |
ARK Investment Management | 6,743,556 | $904,648,000 | 2.17% |
Integral Health Asset Management, LLC | 50,000 | $6,708,000 | 1.93% |
Yorktown Management & Research Co Inc | 18,300 | $2,455,000 | 1.85% |
Interchange Capital Partners, LLC | 8,191 | $1,098,000 | 1.84% |
REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $14,950,000 | 1.76% |